SUVPF Stock: Sartorius AG Stock Price, Analysis & Insights
Get live SUVPF stock price $288.21, comprehensive Sartorius AG stock analysis, charts, news, and expert forecast. Real-time SUVPF stock data and investment insights.
Loading chart data...
Sartorius AG (SUVPF) Overview
Sartorius AG (SUVPF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, SUVPF trades at $288.21 with a market capitalization of 19.90B . Over the past 52 weeks, SUVPF has traded between $208.00 and $312.93 , with the current price positioned at approximately 76% of this range . The stock c...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 19.90B
- Current price: $288.21
- 52-week range: $208.00 - $312.93
- P/E ratio: 106.35
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sartorius AG, a German company established in 1870 and based in Göttingen, is a global supplier of innovative bioprocess solutions and laboratory products and services. The company's extensive portfolio supports life science research, biopharmaceutic...
Company Information
- CEO
- Michael Grosse
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 13573
Contact Information
- Website
- https://www.sartorius.com
- Address
- Otto-Brenner-Strasse 20
- Country
- DE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 106.3)
✓ Higher growth potential with elevated volatility (Beta: 1.45)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sartorius AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sartorius AG
- ⚠Investors should consider how Sartorius AG fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 106.3) requires strong growth to justify
Market Cap
19.90B
P/E Ratio (TTM)
106.35
Beta
1.45
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SUVPF with peer companies:
- Price
- $8.03
- Market cap
- 9.47B
- Price
- $57.56
- Market cap
- 11.94B
- Price
- $5.93
- Market cap
- 13.36B
- Price
- $0.00
- Market cap
- 1.07K
- Price
- $9.10
- Market cap
- 15.79B
- Price
- $118.08
- Market cap
- 18.83B
- Price
- $11.69
- Market cap
- 18.64B
- Price
- $203.66
- Market cap
- 19.82B
- Price
- $14.97
- Market cap
- 22.08B
- Price
- $14.24
- Market cap
- 21.01B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.